skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
MEK Inhibitor RO4987655 (Code C82696)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: MEK Inhibitor RO4987655

Definition: An orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. MEK inhibitor RO4987655 binds to and inhibits MEK, which may result in the inhibition of MEK-dependent cell signaling and the inhibition of tumor cell proliferation. MEK, a dual specificity threonine/tyrosine kinase, is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers.

Label: MEK Inhibitor RO4987655

NCI Thesaurus Code: C82696 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2830219  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
MEK Inhibitor RO4987655

External Source Codes: 
PDQ Closed Trial Search ID 633506
PDQ Open Trial Search ID 633506 (check for NCI PDQ open clinical trial info)
UMLS CUI C2830219

Other Properties:
     Name Value (qualifiers indented underneath)
code C82696
Legacy_Concept_Name MEK_Serine_Threonine_Kinase_Inhibitor_RO4987655
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom